Director Shareholding

AstraZeneca PLC 30 June 2005 Dealing by Directors Companies Act 1985 Sections 324/329 We hereby inform you that on 29 June 2005 the following Directors of AstraZeneca PLC were each granted an award under the terms of the AstraZeneca Performance Share Plan over the Company's USD0.25 Ordinary Shares. Target number of Award price Total interest in Percentage of Name of Director shares awarded per share Normal vesting shares after this shares in issue date award Sir Tom McKillop 104,417 2241p 29 June 2008 197,032 0.012% J R Symonds 47,723 2241p 29 June 2008 59,250 0.004% J S Patterson 41,945 2241p 29 June 2008 42,448 0.003% The AstraZeneca Performance Share Plan was approved by shareholders at the Company's AGM on 28 April 2005. Awards made under the Plan may not generally vest before the third anniversary of the relevant date of grant nor unless the specified performance target(s) have been met at the end of the three year period which, for this award, is 1 January 2005 to 31 December 2007. The performance target that applies to this award is the Company's Total Shareholder Return ('TSR') compared to the TSR of a selected peer group of 12 other pharmaceutical companies. The actual number of shares to which a participant may become unconditionally entitled will depend on the extent to which the performance target(s) have been met. A summary of the Plan, including a more detailed explanation of the performance target(s), can be found in the AstraZeneca Notice of AGM 2005 which is available on the Company's website www.astrazeneca.com. David R. Brennan, a Director of the Company, who is not included in this award, was granted an award of shares under the terms of the AstraZeneca US Executive Performance Share Plan in March 2005 as previously announced. G H R Musker Company Secretary 30 June 2005 This information is provided by RNS The company news service from the London Stock Exchange UG

Companies

AstraZeneca (AZN)
UK 100

Latest directors dealings